Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The following studies are available:
- 4 acute oral toxicity studies in the rat, 2 studies using the reaction mass of diisobutyl esters of adipic acid, glutaric acid and succinic acid; 1 using the methyl esters of this mixture and 2 studies using dibutyl adipate.
- 2 acute inhalations studies: one using the reaction mass of methyl esters and another using di-n-butyl adipate
- 2 dermal studies: one using the reaction mass of methyl esters and the second using di-n-butyl adipate.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- September 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- 1. HYPOTHESIS FOR THE CATEGORY APPROACH (ENDPOINT LEVEL)
The members of the category are all alcohol esters of dicarboxylic acids. All category members are manufactured by reacting an alcohol (methanol, butanol or isobutanol) with single dicarboxylic acids, succinic, glutaric or adipic acids or mixtures of these acids. The ester bonds are effectively metabolised by the body releasing the component alcohols and acids. The difference between members involves 3 parameters: 1) the alcohol used to esterify the acids, 2) the length of the acid molecule (4C, 5C or 6C) and 3) the presence of individual esters or mixtures thereof.
2. CATEGORY APPROACH JUSTIFICATION (ENDPOINT LEVEL
The toxicity profile of the members (ecotoxicity and human health toxicity and the environmental fate) is consistent. All have low acute toxicity potential, are not sensitising, are mildly irritating to eyes and upper respiratory tract (where vapour pressure allows exposure), are not genotoxic or clastogenic (in vivo) and have minimal systemic toxicity. Data are available predominantly for the methyl esters (individual and mixture), dibutyl adipate and diisobutyl esters (mixture). Within the category, read across is used to cover the higher tier human health toxicity studies predominantly.
See attached document with the justification for the category/read-across approach. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- COASOL: DBE-IB
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd.
- Age at study initiation: 8 - 12 weeks
- Fasting period before study: yes
- Housing: The animals were housed in groups of up to four in suspended solid-floor polypropylene cages furnished with woodflakes
- Diet (e.g. ad libitum): yes
- Water (e.g. ad libitum): yes
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25°C
- Humidity (%): 30- 70 %
- Air changes (per hr): 15 changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/dark cycle - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- All animals were dosed once only by gavage using a metal cannula attached to a graduated syringe. The volume administered to each animal was calculated according to its fasted bodyweight at the time of dosing.
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 females. Only females were used as they are typically more sensitive, and are the preferred choice when it is unknown if there is a sex difference in toxicity
- Control animals:
- no
- Details on study design:
- 1 animal dosed first, then in the absence of toxicity at the dose of 2000 mg/kg bw/day 4 additional animals were dosed with 2000 mg/kg bw/day. Clinical observations were made at 0.5, 1, 2, and 4 hours following dosing and then once daily for the remaining 14 days. Individual bodyweights were recorded at day 0 and day 7. At the end of observation period animals were euthenized by cervical dislocation and subject to gross necropsy consisting of external examination and opening of the abdominal and thoracic cavities. Any macroscopic abnormalities were noted.
- Statistics:
- not applicable
- Preliminary study:
- not applicable
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- There were no deaths
- Clinical signs:
- other: There were no clinical signs of toxicity
- Gross pathology:
- No abnormalities identified at necropsy
- Other findings:
- none
- Interpretation of results:
- not classified
- Conclusions:
- There were no deaths at the limit dose of 2000 mg/kg bw. Therefore this substance does not require classification for acute oral toxicity.
- Executive summary:
An acute oral toxicity study in female rats was conducted according to OECD TG 420 and in accordance with the Principles of Good Laboratory Practice (GLP). One female animal dosed first, then in the absence of toxicity at the dose of 2000 mg/kg bw/day four additional animals were dosed with 2000 mg/kg bw/day. Clinical observations were made at 0.5, 1, 2, and 4 hours following dosing and then once daily for the remaining 14 days. Individual bodyweights were recorded at day 0 and day 7. At the end of observation period animals were euthenized by cervical dislocation and subject to gross necropsy consisting of external examination and opening of the abdominal and thoracic cavities. Any macroscopic abnormalities were noted. There were no deaths and no clinical signs of toxicity, based on which the the substance does not require classification for acute oral toxicity.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 2006-09-05 to 2006-11-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- The animals were nulliparous and non-pregnant. After an acclimatisation period of at least five days the animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and a number written on a cage card. At the start of the study the animals were eight to twelve weeks of age. The bodyweights fell within an interval of ± 20% of the mean initial bodyweight of the first treated group.
The animals were housed in groups of three in suspended solid-floor polypropylene cages furnished with woodflakes. With the exception of an overnight fast immediately before dosing and for approximately three to four hours after dosing, free access to mains drinking water and food was allowed throughout the study. The diet, drinking water and bedding were routinely analysed and were considered not to contain any contaminants that would reasonably be expected to affect the purpose or integrity of the study.
The temperature and relative humidity were set to achieve limits of 19 to 25°C and 30 to 70% respectively. Any occasional deviations from these targets were considered not to have affected the purpose or integrity of the study. The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 4.96 ml/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: based on available historical data/information - Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 3 female animals
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: 30 min, 1h, 2h, 4h, then daily up to 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights - Statistics:
- not applicable
- Preliminary study:
- not applicable
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths.
- Clinical signs:
- other: Hunched posture and pilo-erection were noted in one animal two days after dosing and in one animal three days after dosing. Animals appeared normal three or four days after dosing.
- Gross pathology:
- No abnormalities were noted at time of necropsy.
- Other findings:
- none
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- The acute oral median lethal dose (LD50) of the test material in the female Sprague-Dawley CD strain rat was estimated to be greater than 5000 mg/kg bodyweight. Therefore DBE is not classified according to Annex VI of the Directive 67/548/CEE and according to EU Regulation 1272/2008 (CLP).
- Executive summary:
DBE has been tested in an acute oral toxicity study using female Sprague Dawley rats, according to OECD guideline n° 423 and EU guideline no. B.1 tris in compliance with Good Laboratory Practice. The test item was administered without vehicle once by oral route (gavage) to a group of three fasted female rats at a dose level of 5000 mg/kg. Clinical signs, mortality and body weight gain were checked for a period of up to 14 days after the single administration of DBE. All animals were subjected to necropsy. No mortality was recorded during the study. Body weight gain of the treated animals was not affected by treatment. At necropsy, no abnormalities were observed in any animal. As the LD 50 is higher than 5000 mg/kg, DBE is not classified according to Annex VI of the Directive 67/548/CEE and according to EU Regulation 1272/2008 (CLP).
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- supporting study
- Study period:
- 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: CRL:CD
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Doses:
- 13000, 14500, 16000, 20000 mg/kg bw
- No. of animals per sex per dose:
- 10 males per dose
- Control animals:
- no
- Preliminary study:
- not applicable
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 16 426 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 15 295 - < 18 189
- Remarks on result:
- other: Slope: 15.9
- Clinical signs:
- other:
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral toxicity in male rats was very low with the LD50 >16,000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1951
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Male albino rats were administered the test substance (20% dispersion) at levels of 7.95 g/kg, 15.8 g/kg and 31.6 g/kg observed for mortality and clinical signs of toxicity
- GLP compliance:
- no
- Remarks:
- study conducted prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 90-120 grams
- Fasting period before study: no - Route of administration:
- oral: gavage
- Vehicle:
- other: 1% Tergitol 7
- Details on oral exposure:
- Male albino rats were administered the test substance (20% dispersion) at levels of 7.95 g/kg, 15.8 g/kg and 31.6 g/kg observed for mortality and clinical signs of toxicity
- Doses:
- 7.95 g/kg, 15.8 g/kg and 31.6 g/kg
- No. of animals per sex per dose:
- 5 male rats/dose
- Control animals:
- no
- Details on study design:
- Male albino rats were administered the test substance (20% dispersion) at levels of 7.95 g/kg, 15.8 g/kg and 31.6 g/kg observed for mortality and clinical signs of toxicity for 14 days
- Statistics:
- Thompson's method of estimating the median-effective dose (LD50) was used.
- Preliminary study:
- not applicable
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 112 600 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 11.26 gm/kg.
- Mortality:
- 100 per cent mortality was noted in the 15.8 and 31.6 g/kg group.
- Clinical signs:
- other: Animals of the 15.8 and 31.6 g/kg group appeared prostrated and narcotized within 4 hours pots adminsitration
- Gross pathology:
- Autopsy of the animals found dead from the 15.8 and 31.6 g/kg dose group revealed congested liver and kidney and gastrointestinal irritation
- Other findings:
- none
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 11.26 gm/kg
- Executive summary:
Male rats (non-fasted) were administered n-butyl adipate as a 20% dispersion in 1% Tergitol 7 doses of 7.95 g/kg, 15.8 and 31.6 g/kg and observed for 14 days. Thompson's method of estimating the median-effective dose (LD50) was used. No clinical signs were noted. All the rats from the 15.8 and 31.6 g/kg dose group died approximately 1 day after administration. Autopsy of the animals found dead from the 15.8 and 31.6 g/kg dose group revealed congested liver and kidney and gastrointestinal irritation. The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 11.26 gm/kg.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1951
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Male albino rats were administered the test substance (20% dispersion) at levels of 7.95 g/kg and twice this dose (15.9 g/kg) and observed for mortality and clinical signs of toxicity
- GLP compliance:
- no
- Remarks:
- study conducted prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sherman
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: in-house raised
- Age at study initiation: 5-6 weeks
- Weight at study initiation: 90-120 grams
- Fasting period before study: no
- Diet (e.g. ad libitum): Rockland rat diet - Route of administration:
- oral: gavage
- Vehicle:
- other: 1% Tergitol 7
- Details on oral exposure:
- Male Sherman strain rats (non-fasted) were administered a 20% dispersion in 1% Tergitol 7 doses of 7.95 g/kg and another group adminsitered twice the dose (15.9 g/kg).
- Doses:
- 7.95 g/kg and twice this dose (15.9 g/kg)
- No. of animals per sex per dose:
- no information available
- Control animals:
- not specified
- Details on study design:
- Male Sherman strain rats (non-fasted) were administered a 20% dispersion in 1% Tergitol 7 doses of 7.95 g/kg and another group adminsitered twice the dose (15.9 g/kg) and observed for 14 days
- Statistics:
- Thompson's method of estimating the median-effective dose (LD50) was used.
- Preliminary study:
- not applicable
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 129 300 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 9 850 - 169 700
- Remarks on result:
- other: The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 12.93 (9.85 to 16.97) gm./kg.
- Mortality:
- The majority of the rats died within 24 hours and some instances (1-2 rats) of sporadic mortality was noted between 36-48 hours
- Clinical signs:
- other: No signs noted
- Gross pathology:
- Autopsy findings indicated severe damage to the gastrointestinal tract.
- Other findings:
- none
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 12.93 (9.85 to 16.97) gm./kg.
- Executive summary:
Male Sherman strain rats (non-fasted) were administered n-butyl adipate as a 20% dispersion in 1% Tergitol 7 doses of 7.95 g/kg and another group adminsitered twice the dose (15.9 g/kg) and observed for 14 days. Thompson's method of estimating the median-effective dose (LD50) was used. No clinical signs were noted. The majority of the rats died within 24 hours and some instances (1-2 rats) of sporadic mortality was noted between 36-48 hours. Autopsy findings indicated severe damage to the gastrointestinal tract. The R.F. LD50 of n-butyl adipate for male albino rats fed a 20% dispersion in 1% Tergitol 7 by stomach tube in a single doee was 12.93 (9.85 to 16.97) gm./kg.
Referenceopen allclose all
None
None
None
None
None
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- April 16 to May 18, 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Justification for type of information:
- 1. HYPOTHESIS FOR THE CATEGORY APPROACH (ENDPOINT LEVEL)
The members of the category are all alcohol esters of dicarboxylic acids. All category members are manufactured by reacting an alcohol (methanol, butanol or isobutanol) with single dicarboxylic acids, succinic, glutaric or adipic acids or mixtures of these acids. The ester bonds are effectively metabolised by the body releasing the component alcohols and acids. The difference between members involves 3 parameters: 1) the alcohol used to esterify the acids, 2) the length of the acid molecule (4C, 5C or 6C) and 3) the presence of individual esters or mixtures thereof.
2. CATEGORY APPROACH JUSTIFICATION (ENDPOINT LEVEL
The toxicity profile of the members (ecotoxicity and human health toxicity and the environmental fate) is consistent. All have low acute toxicity potential, are not sensitising, are mildly irritating to eyes and upper respiratory tract (where vapour pressure allows exposure), are not genotoxic or clastogenic (in vivo) and have minimal systemic toxicity. Data are available predominantly for the methyl esters (individual and mixture), dibutyl adipate and diisobutyl esters (mixture). Within the category, read across is used to cover the higher tier human health toxicity studies predominantly.
See attached document with the justification for the category/read-across approach. - Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- no
- Remarks:
- but with quality assurance documentation
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Young adult male and female Crl:CD BR rats were received from Charles River Breeding Laboratories. Rats were quarantined for approximately 1 week prior to testing and were weighed and observed 3 times during the quarantine period. During the quarantine period rats were housed singly in 5” x 11" x 7" suspended, stainless steel, wire mesh cages. After exposure, rats were housed (sexes separate) either 1 or 2 per cage in 8” x 14" x 8”cages. Prior to exposure, rats’ tails and cage cards were color-coded so that individual rats could be identified after exposure. For rats housed in pairs, the rat with the lower number was identified by a slash in the right ear.
On the day of exposure, rats were approximately 7-8 weeks old; male rats weighed 238-281 g and female rats weighed 174-222 g. Except during exposure, Purina Certified Rodent Chow and water were available ad libidum. Animal rooms were maintained on a timer-controlled, 12 hour/12 hour light/dark cycle.
Environmental conditions of the animal rooms were targeted for a temperature of 23°+ 2°C and relative humidity of 50 % + 10 %. Excursions outside these ranges were judged to have been of insufficient magnitude and/or duration to have adversely affected the validity of the study. - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Details on inhalation exposure:
- For the LC50 determination, groups of 5 male and 5 female rats were individually restrained in stainless steel restrainers with conical nose pieces and exposed nose-only to DBE. Each restrainer was inserted into a 38-L cylindrical exposure chamber such that only the nose of each protruded into the chamber. To determine whether the ocular response was diminished by nose-only exposure, an additional group of 4 male rats was placed in a stainless steel and aluminum wire mesh cage within the exposure chamber and exposed whole-body.
Each group of rats was exposed for a single. 4-hour period to an aerosol / vapor mixture of DBE in air. Rats were observed for clinical signs of toxicity (e.g., general physical and clinical disposition. including unusual movements, respiration. etc.) before and during exposure. upon removal from the animal restrainers approximately 30 minutes after the cessation of exposure, and daily thereafter (weekends and holidays excluded unless warranted by the rats' condition). During the exposure. the use of restrainers limited the observations mainly to the presence of nasal or oral discharges. In addition. a sharp rap was periodically delivered to the exposure chamber and rats were observed for a general startle response (rapid movement) during the exposure. This procedure was used primarily as a gross indicator of unconsciousness or death. Rats were weighed prior to exposure, and were weighed daily. weekends and holidays excluded except when warranted by the rats' condition, during the 14-day recovery period.
Atmosphere Generation
DBE was generated by atomization. Test atmospheres of DBE were generated by atomizing the liquid test material using an Airlife, Solo-Sphere Nebulizer. Conditioned, filtered houseline air (approximately 8-16 L/min) was used to generate the aerosol and to carry the aerosol directly into the 38 L cylindrical, glass exposure chamber. Located immediately inside the chamber was a plastic deflection plate (approximately 12.5 cm diameter) which acted as a baffle to promote turbulent flow and facilitate uniform distribution of the aerosol within the chamber. Chamber atmospheres were exhausted through tandem, dry-ice cold traps and an MSA activated charcoal/HEPA filter cartridge prior to discharge into a fume hood - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 3.5, 5.6, 11.0 mg/L DBE;
- No. of animals per sex per dose:
- 5 males;
5 females; - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:starting 30 min after exposure, then daily for 14 days
- Necropsy of survivors performed: no data
- Other examinations performed: opthalmology - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 11 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No rats died following exposure to DBE at atmospheric concentrations as great as 11 mg/L, the highest concentration tested.
- Clinical signs:
- other: Clinical signs of toxicity observed in some male and female rats during the recovery period included red nasal, ocular or oral discharges, wet, yellow-stained perineum, and hunched posture. All clinical signs were transient and had resolved by study day 4
- Body weight:
- Rats from all exposure groups exhibited slight to severe body weight losses 1 day after exposure (group average weight losses ranged from approximately 5-11% and 2-9% of initial body weight in male and female rats, respectively). In addition, some transient, slight to moderate weight losses occurred in some male and female rats during the first or second weeks of the recovery period.
- Other findings:
- Prior to exposure, the eyes of rats from the 11 mg/L group were evaluated and considered ophthalmoscopically normal. After exposure, the eyes of rats from the 3.5 or 11 mg/L groups were considered to be ophthalmoscopically normal; the corneal and pupillary reflexes were normal. At 5.6 mg/L, however, bilateral mild chemosis (edema/swelling) of the bulbar conjunctivae was found in all rats. Although a subepithelial corneal opacity was also noted in 1 rat exposed to 5.6 mg/L, this finding was believed to be due to a preexisting injury and not compound-related.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Under the conditions of this study, the 4-hour LC50 for DBE exceeds 11 mg/L, the highest concentration tested.
- Executive summary:
DBE has been tested in an acute inhalation toxicity study using Crj: CD(SD) rats, according to OECD guideline n° 403 and EU guideline n° B.2 with quality assurance documentation.
5 males and 5 females per dose were exposed to 3.5, 5.6 or 11.0 mg/L DBE for 4 h via inhalation (nose only). Clinical signs, mortality and body weight gain were checked for a period of up to 14 days after the single exposure to DBE. All animals were subjected to necropsy. No rats died following exposure to DBE at atmospheric concentrations as great as 11 mg/L, the highest concentration tested. Rats from all exposure groups exhibited slight to severe body weight losses 1 day after exposure (group average weight losses ranged from approximately 5-11% and 2-9% of initial body weight in male and female rats, respectively). In addition, some transient, slight to moderate weight losses occurred in some male and female rats during the first or second weeks of the recovery period. Clinical signs of toxicity observed in some male and female rats during the recovery period included red nasal, ocular or oral discharges, wet, yellow-stained perineum, and hunched posture. All clinical signs were transient and had resolved by study day 4. Ophthalmoscopic findings in the 5.6 mg/L group were believed to be due to a preexisting injury and not compound related as no comparable findings were seen in the 3.5 or 11 mg/L groups.
As the LC50 is higher than 11 mg/L, DBE is not classified according to Annex VI of the Directive 67/548/CEE and according to EU Regulation 1272/2008 (CLP).
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1951
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Groups of animals were exposed to vapours and aerosols of n-butyl adipate and observed for mortality and other signs for 14 days
- GLP compliance:
- no
- Remarks:
- study conducted prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Young mature male rats were used for the study
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- not specified
- Details on inhalation exposure:
- In the first experiment, 6 young mature male rats were exposed to substantially saturated vapor at room temperature for 8 hours. The vapor was generated by passing air at a rate of 2.5 litres/minute through 50 ml of n-butyl adipate contained in a gas washing bottle.
In the second experiment, 6 young mature male rats were exposed for 8 hours to a fog of n-butyl adipate produced by a vaponefrin nebulizer (equivalent to 25 mg/litre of n-butyl adipate) - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 8 h
- Concentrations:
- substantially saturated vapours and an aerosol equivalent to 25 mg/l of n-butyl adipate
- No. of animals per sex per dose:
- 6 young mature male rats
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: yes - Statistics:
- no information available
- Preliminary study:
- not applicable
- Sex:
- male
- Dose descriptor:
- LC0
- Effect level:
- > 21.86 mg/L air (nominal)
- Based on:
- other: calculated value - converting substantially saturated vapor generated at room temperature
- Exp. duration:
- 8 h
- Remarks on result:
- other: refer to conversion below
- Mortality:
- No mortality was noted in both the exposures
- Clinical signs:
- other: no signs noted
- Body weight:
- body weight gains were normal
- Gross pathology:
- no information available
- Other findings:
- none
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- Based on the results of the study, no mortality was noted in rats exposed at substantially saturated vapors (calculated 21.86 mg/l) of n-butyl adipate.
- Executive summary:
In the first experiment, 6 young mature male rats were exposed to substantially saturated vapor at room temperature for 8 hours. The vapor was generated by passing air at a rate of 2.5 litres/minute through 50 ml of n-butyl adipate contained in a gas washing bottle.
In the second experiment, 6 young mature male rats were exposed for 8 hours to a fog of n-butyl adipate produced by a vaponefrin nebulizer (equivalent to 25 mg/litre of n-butyl adipate). No mortality and signs of toxicity were noted, body weight gains were normal. Based on the results, the calculated LC0 of n-butyl adipate was greater than 21.86 mg/l.
Referenceopen allclose all
None
vapor pressure of dibutyl adipate - 2.1 x 10 -2 Pa at 25 degree celsius - OECD TG 104 (source SIDS)
equivalent to 210 Pa - 1.575 mm Hg leading to a saturated vopr concentration of 2072.368421 ppm, molecular weight of 258.35.
According to Patty's handbook - 1 mg/l - 94.8 ppm, therefore 2072.368421 is equivalent to 21.86 mg/l.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- January 09 to March 26, 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Justification for type of information:
- 1. HYPOTHESIS FOR THE CATEGORY APPROACH (ENDPOINT LEVEL)
The members of the category are all alcohol esters of dicarboxylic acids. All category members are manufactured by reacting an alcohol (methanol, butanol or isobutanol) with single dicarboxylic acids, succinic, glutaric or adipic acids or mixtures of these acids. The ester bonds are effectively metabolised by the body releasing the component alcohols and acids. The difference between members involves 3 parameters: 1) the alcohol used to esterify the acids, 2) the length of the acid molecule (4C, 5C or 6C) and 3) the presence of individual esters or mixtures thereof.
2. CATEGORY APPROACH JUSTIFICATION (ENDPOINT LEVEL
The toxicity profile of the members (ecotoxicity and human health toxicity and the environmental fate) is consistent. All have low acute toxicity potential, are not sensitising, are mildly irritating to eyes and upper respiratory tract (where vapour pressure allows exposure), are not genotoxic or clastogenic (in vivo) and have minimal systemic toxicity. Data are available predominantly for the methyl esters (individual and mixture), dibutyl adipate and diisobutyl esters (mixture). Within the category, read across is used to cover the higher tier human health toxicity studies predominantly.
See attached document with the justification for the category/read-across approach. - Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, F-76410 Saint Aubin les Elbeuf, France;
- Weight at study initiation: males: 266 ± 2 g, females: 247 ±10 g;
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 6 days;
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 60 ± 20
- Photoperiod (hrs dark / hrs light): 12/12; - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 5 x 7 cm²; shaved backs and flanks
- % coverage: < 10%;
- Type of wrap if used: gauze
REMOVAL OF TEST SUBSTANCE
- Washing (if done): not specified;
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): not specified;
- Concentration (if solution): 2000 mg/kg bw; - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw;
- No. of animals per sex per dose:
- 5 males;
5 females; - Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations: at least once daily; weighting: at days 1 (pre-administration), 5, 8, and 15
- Necropsy of survivors performed: yes - Preliminary study:
- not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured.
- Clinical signs:
- other: No clinical signs of toxicity were detected.
- Gross pathology:
- No signs of gross pathology have been detected
- Other findings:
- none
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of the current study, the test article DBE showed no signs of toxicity in female and male rats over a period of 14 days when applied dermally once at 2000 mg/kg bw. The LD50 can therefore be concluded to be greater than 2000 mg/kg bw. Based on this Result DBE is not classified according to Annex VI of the Directive 67/548/CEE and according to EU Regulation 1272/2008 (CLP).
- Executive summary:
DBE has been tested in an acute dermal toxicity study using Crj: CD(SD) rats, according to OECD guideline no. 402 and EU guideline no. B.3 in compliance with Good Laboratory Practice. The test item was applied once under semiocclusive conditions to the shaved backs and flanks of the animals at a dose level of 2000 mg/kg for 24 h (5 males + 5 females per dose, 5 x 7 cm²). Clinical signs, mortality and body weight gain were checked for a period of up to 14 days after the single administration of DBE. All animals were subjected to necropsy. No mortality was recorded in both groups during the study. Body weight gain of the treated animals was not affected by treatment. At necropsy, no abnormalities were observed in any animal. As the LD 50 is higher than 2000 mg/kg, DBE is not classified according to Annex VI of the Directive 67/548/CEE and according to EU Regulation 1272/2008 (CLP).
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- supporting study
- Study period:
- 1950
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- See attached document with the justification for the category/read-across approach.
- Principles of method if other than guideline:
- similar to OECD TG 402
- GLP compliance:
- no
- Remarks:
- study conducted prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no information available
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- Undiluted n-butyl adipate was held in contact with hair-free trunk of male albino rabbits by means of impervious dams of Vinylite sheeting.
- Duration of exposure:
- 24 hours
- Doses:
- 5, 10 and 20 ml/kg
- No. of animals per sex per dose:
- 5 ml/kg - 3 rabbits,
10 ml/kg - 4 rabbits and
20 ml/kg - 10 rabbits - Control animals:
- no
- Details on study design:
- Undiluted n-butyl adipate was held in contact with hair-free trunk of male albino rabbits by means of impervious dams of Vinylite sheeting.
- Statistics:
- no information available
- Preliminary study:
- not applicable
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 20 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: The estimated R.F. LD50 of undiluted n-butyl adipate is > 20 ml/kg (converted value of 19240 mg/kg, based on relative density of 0.962 g/ml at 25 °C) when tested on male albino rabbits.
- Mortality:
- At the highest tested level of 20 ml/kg, three out of ten rabbits exposed to undiluted n-butyl adipate succumbed while no mortalities were noted at the lower tested groups of 10 and 5 ml/kg
- Clinical signs:
- other: no information available
- Gross pathology:
- no information available
- Other findings:
- none
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The estimated R.F. LD50 of undiluted n-butyl adipate is > 20 ml/kg (converted value of 19240 mg/kg, based on relative density of 0.962 g/ml at 25 °C) when tested on male albino rabbits.
- Executive summary:
In this study, undiluted n-butyl adipate was held in contact with hair-free trunk of male albino rabbits by means of impervious dams of Vinylite sheeting at dose levels of 5, 10 and 20 ml/kg. At the highest tested level of 20 ml/kg, three out of ten rabbits exposed to undiluted n-butyl adipate succumbed while no mortalities were noted at the lower tested groups of 10 and 5 ml/kg. Normal weight gain was observed in most of the surviving animals across the tested groups. The estimated R.F. LD50 of undiluted n-butyl adipate is > 20 ml/kg (converted value of 19240 mg/kg, based on relative density of 0.962 g/ml at 25 °C) when tested on male albino rabbits.
Referenceopen allclose all
None
None
Endpoint conclusion
- Value:
- mg/kg bw
Additional information
Oral:
There are no acute oral studies available on the reaction mass of dibutyl esters of adipic and glutaric acid. However there are acute oral toxicity studies on the category members used for read across and also on one of the components of the reaction mass (dibutyl adipate). The data available are all very consistent indicating a very low order of acute toxicity values (LD50 >>2000 mg/kg bw). Given the consistency across the category members the LD50 of the reaction mass is expected to be >2000 mg/kg bw.
Inhalation:
The vapour pressure of the reaction mass is very low and as such an acute exposure is considered unlikely via the inhalation route. However, the available data on the methyl esters and dibutyl adipate indicate a very low level of acute inhalation toxicity. As such this substance is not expected to be acutely toxic via the inhalation route.
Dermal:
In the available data on dibutyl adipate, the acute dermal toxicity was very low (LD50 >5000 mg/kg bw). This is consistent with the available data on the methyl esters where the dermal LD50 was also > 2000 mg/kg bw. Therefore dibutyl esters reaction mass is considered to also have a dermal LD50 of >2000 mg/kg bw.
A further comparison of acute toxicity can be found in the category justification attached at section 0 and 13.
Justification for classification or non-classification
Not classified due to lack of acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)